AstraZeneca Said to Settle More Seroquel Lawsuits

AstraZeneca Plc agreed to pay $150 million to settle more lawsuits claiming its antipsychotic drug Seroquel causes diabetes, pushing the amount the drugmaker has paid to resolve cases over the medicine to almost $350 million, people familiar with the accords said.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.